Literature DB >> 3377033

Cardiovascular disease in women.

W P Castelli1.   

Abstract

Cardiovascular disease is the leading cause of death in American women. Atherosclerotic diseases, primarily myocardial infarction and stroke, are important causes of morbidity and mortality among women. Contrary to popular belief, the actual number of myocardial infarctions in men and women is similar, although women develop cardiovascular disease an average of 10 years later than do men. Total serum cholesterol level is a major indicator of risk of coronary heart disease; for every 1% increase in the total serum cholesterol level, a 2% increase in incidence of coronary heart disease is found. A high level of low-density lipoproteins is an independent risk factor for coronary heart disease in both mean and women, but high triglyceride level is an independent risk factor only in women. Conversely, the higher the level of high-density lipoprotein, the lower the risk of coronary heart disease. To reduce the risk of coronary heart disease, target levels of total serum cholesterol must be lowered from 300 to 200 mg/dl. If the total cholesterol/high-density lipoprotein ratio is greater than or equal to 4.5 of if the low-density lipoprotein concentration is greater than 150 mg/dl, the patient is at high risk for coronary heart disease. Clinical trials that use diet or drugs to lower serum cholesterol levels have consistently shown a 2% reduction in the incidence of coronary heart disease for every 1% reduction in total serum cholesterol level.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3377033     DOI: 10.1016/0002-9378(88)90189-5

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  19 in total

1.  "Normal" blood glucose and coronary risk.

Authors:  E Barrett-Connor; D L Wingard
Journal:  BMJ       Date:  2001-01-06

Review 2.  Physical activity and high density lipoprotein cholesterol levels: what is the relationship?

Authors:  P F Kokkinos; B Fernhall
Journal:  Sports Med       Date:  1999-11       Impact factor: 11.136

Review 3.  The effect of physical exercise on endothelial function.

Authors:  Samanta Di Francescomarino; Adolfo Sciartilli; Valentina Di Valerio; Angela Di Baldassarre; Sabina Gallina
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

4.  Stroke mortality trends and antihypertensive drug use.

Authors:  R L Smith; E R Pinckney
Journal:  Am J Public Health       Date:  1993-11       Impact factor: 9.308

5.  Cardiometabolic risk profiles in pre- versus postmenopausal women with spinal cord injury:: preliminary findings.

Authors:  Hillary Hosier; Suzanne L Groah; Alex V Libin; Emily Tinsley; Patricia Burns; Mark S Nash
Journal:  Top Spinal Cord Inj Rehabil       Date:  2012

6.  Risk factors for atherogenesis in children with spina bifida.

Authors:  C Rendeli; M Castorina; E Ausili; E Girardi; C Fundarò; M Caldarelli; E Salvaggio
Journal:  Childs Nerv Syst       Date:  2004-04-07       Impact factor: 1.475

7.  Sulforaphane attenuates the development of atherosclerosis and improves endothelial dysfunction in hypercholesterolemic rabbits.

Authors:  George S G Shehatou; Ghada M Suddek
Journal:  Exp Biol Med (Maywood)       Date:  2015-10-20

8.  Estrogen reduces aldosterone, upregulates adrenal angiotensin II AT2 receptors and normalizes adrenomedullary Fra-2 in ovariectomized rats.

Authors:  Miroslava Macova; Ines Armando; Jin Zhou; Gustavo Baiardi; Dmitri Tyurmin; Ignacio M Larrayoz-Roldan; Juan M Saavedra
Journal:  Neuroendocrinology       Date:  2008-08-04       Impact factor: 4.914

9.  Reduction of ventricular M2 muscarinic receptors in cardiomyopathic hamster (CHF 147) at the necrotic stage of the myopathy.

Authors:  M Wilkinson; M Horackova; A Giles
Journal:  Pflugers Arch       Date:  1994-04       Impact factor: 3.657

10.  Myocardial perfusion defects and coronary risk factors in symptomatic and asymptomatic elderly women.

Authors:  Su Jin Lee; Kyung-Han Lee; So-Mi Park; Eun Jeong Lee; Hyun Woo Chung; Young Seok Cho; Joon Young Choi; Byung-Tae Kim
Journal:  Int J Cardiovasc Imaging       Date:  2007-09-05       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.